https://orcid.org/0000-0002-1039-3878
About the Authors
- Hakim Benkirane
-
Roles Conceptualization, Formal analysis, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Computer Science (MICS), Gif-sur-Yvette, France, IHU PRISM, National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France, Inserm U1018 Oncostat, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France, Université Paris-Saclay, Faculty of Medicine, Le Kremlin Bicêtre, France
- Maria Vakalopoulou
-
Roles Supervision, Writing – original draft
Affiliations Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Computer Science (MICS), Gif-sur-Yvette, France, IHU PRISM, National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France
- David Planchard
-
Roles Data curation
Affiliations Université Paris-Saclay, Faculty of Medicine, Le Kremlin Bicêtre, France, Department of Medical Oncology, Thoracic Group and International Center for Thoracic Cancers (CICT), Gustave Roussy, Université Paris-Saclay, Villejuif, France
- Julien Adam
-
Roles Data curation
Affiliations Université Paris-Saclay, Faculty of Medicine, Le Kremlin Bicêtre, France, Inserm U1186, Gustave Roussy, Université Paris-Saclay, Villejuif, France
- Ken Olaussen
-
Roles Validation, Data curation
Affiliations Université Paris-Saclay, Faculty of Medicine, Le Kremlin Bicêtre, France, Inserm U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France
- Stefan Michiels
-
Contributed equally to this work with: Stefan Michiels, Paul-Henry Cournède
Roles Validation, Supervision, Funding acquisition, Writing – original draft, Writing – review & editing
Affiliations Inserm U1018 Oncostat, Équipe Labellisée Ligue Contre le Cancer, Université Paris-Saclay, Villejuif, France, Bureau de Biostatistique et d’Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France
- Paul-Henry Cournède
-
Contributed equally to this work with: Stefan Michiels, Paul-Henry Cournède
Roles Validation, Supervision, Funding acquisition, Resources, Writing – original draft, Writing – review & editing
* E-mail: paul-henry.cournede@centralesupelec.fr
Affiliations Université Paris-Saclay, CentraleSupélec, Laboratory of Mathematics and Computer Science (MICS), Gif-sur-Yvette, France, IHU PRISM, National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: DP has received consulting fees and honoraria for advisory roles and lectures from AstraZeneca, Abbvie, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Daiichi Sankyo, Eli Lilly, Merck, Novartis, Janssen, Pfizer, Roche, Pierre-fabre, Takeda, ArriVent, Mirati, and Seagen; has been principal or co-investigator on clinical trials (institutional financial interests) funded by AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Pfizer, Roche, Medimmun, Sanofi-Aventis, Taiho Pharma, Novocure, Daiichi Sankyo, Abbvie, Janssen, Pierre-fabre, Takeda, ArriVent, Mirati, and Seagen; and has received travel, accommodations and expenses from AstraZeneca, Roche, Novartis, and Pfizer. The remaining authors declare no competing interests.